Indications 

Cogentin Injection is utilized as an adjunctive treatment for all forms of Parkinsonism, a group of conditions characterized by movement problems akin to those seen in Parkinson’s disease, such as tremors, slow movements, and limb stiffness. 

Moreover, Cogentin Injection is used to manage extrapyramidal disorders (involuntary movements) caused by neuroleptic drugs, excluding tardive dyskinesia. 

As an anticholinergic medication, Cogentin Injection functions by inhibiting the activity of the neurotransmitter acetylcholine, thereby alleviating symptoms associated with these conditions. 

Uses and Dosage 

Familiarize yourself with the preparation and usage instructions for Cogentin Injection provided by your doctor when using it at home.  

Before administering this medication and every time you refill your prescription, carefully review the medication guide and patient information leaflet available. Should any inquiries arise, seek guidance from your doctor or pharmacist. 

Cogentin injection can be administered intravenously or intramuscularly, multiple times daily, or as a single dose before bedtime. 

The dosage of this medication is individualized according to the patient’s age, weight, medical conditions, and response to the treatment. 

To minimize the potential for side effects, your doctor may recommend initiating this medication at a low dosage and progressively adjusting it. Adhere closely to your doctor’s guidance. 

If Cogentin Injection is being used to manage side effects from another medication, follow either a prescribed routine or take it as directed by your doctor. 

In cases of Parkinson’s disease, your doctor may modify the dosage of other medications (e.g., levodopa). 

For optimal results, follow your prescribed dosage regimen, avoiding any self-adjustments in dose, frequency, or duration. If prescribed for daily use, administer Cogentin Injection consistently at the same daily times.  

Extended use of this medication may lead to reduced effectiveness; consult your doctor if its efficacy diminishes. 

Discontinue Cogentin Injection as directed to avoid exacerbating certain conditions, as a gradual dose reduction may be necessary. 

Side Effects 

The potential adverse effects of Cogentin Injection are outlined below. Promptly tell your doctor if any of these symptoms persist or deteriorate. 

Common Side Effects 

• Dry mouth 
• Blurred vision 
• Constipation 
• Nausea 

Serious Side Effects 

• Severe dry mouth impairing speech or swallowing 
• Reduced or absent urination 
• Involuntary muscle movements 
• Severe vomiting and constipation 
• Rapid heart rate 
• Muscle weakness 
• Blurred vision, tunnel vision, eye pain, or seeing halos around lights 
• Confusion, hallucinations 
• Severe skin rash 

Contact your doctor immediately if any of the severe symptoms above occur. 

Allergic Reactions 

In rare cases, Cogentin injection may trigger a severe allergic response. Immediate medical assistance is needed if you observe signs of an allergic reaction, such as: 

• Hives 
• Difficulty breathing 
• Face, lips, tongue, or throat swelling 

This list does not cover all side effects of Cogentin Injection. Report any other symptoms you may experience to your healthcare provider. 

Cautions 

Before administering Cogentin Injection, inform your doctor if you have any known allergies, particularly to benztropine or to any of its inactive components. 

Seek advice from your doctor before administering Cogentin Injection if you have a history of: 

• Glaucoma (angle-closure type) in oneself or family 
• Respiratory conditions (e.g., asthma, emphysema) 
• Diarrhea caused by infection 
• Heart issues (e.g., angina, heart attack, heart failure, rapid/irregular heartbeat) 
• High/low blood pressure 
• Gastrointestinal conditions (e.g., chronic constipation, ileus, ulcerative colitis, bowel obstruction) 
• Blockages in bladder, esophagus, stomach, or intestines 
• Kidney disease 
• Liver disease 
• Mental/mood disorders (e.g., anxiety, dementia, psychosis) 
• Muscle disease (myasthenia gravis) 
• Nerve disease (autonomic neuropathy) 
• Seizures 
• Gastrointestinal problems (e.g., acid reflux, hiatal hernia, ulcer) 
• Stroke 
• Overactive thyroid (hyperthyroidism) 
• Urinary issues (e.g., enlarged prostate, neurogenic bladder) 
• Substance use disorder (e.g., drug/alcohol overuse or addiction) in oneself or family 

Potassium tablets/capsules and pramlintide can interact with Cogentin Injection. To minimize the risk of such interactions, inform your doctor of all the medications you are currently taking, including prescription and over-the-counter drugs, vitamins, and herbal products. 

Review the labels of all your medications, including allergy or cough-and-cold products, as they may contain ingredients leading to drowsiness. Consult your pharmacist for safe usage of such products.  

Moreover, inform your doctor or pharmacist if you are concurrently using substances that induce drowsiness, including: 

• Opioid pain or cough relievers (e.g., codeine, hydrocodone) 
• Alcohol 
• Marijuana (cannabis) 
• Sleep or anxiety medications (e.g., alprazolam, lorazepam, zolpidem)  
• Muscle relaxants (e.g., carisoprodol, cyclobenzaprine) 
• Antihistamines (e.g., cetirizine, diphenhydramine) 

Cogentin Injection can potentially disrupt specific medical or laboratory tests (brain scans for Parkinson’s disease), leading to inaccurate results. Inform laboratory staff and all your healthcare providers about your use of this medication. 

The use of Cogentin Injection can reduce perspiration, increasing the risk of heat stroke. Take precautions to avoid overheating or dehydration when exercising or in hot conditions. 

Avoid engaging in activities that require focus or precision until you are aware of the impact of Cogentin on your cognitive and motor functions, as it may impair your reactions. 

The use of Cogentin Injection reduces saliva production, which can elevate the risk of dental issues like cavities and gum disease. Maintain proper dental hygiene practices, including brushing and flossing, and schedule routine dental examinations. 

The potential impact of Cogentin Injection on fetal development is uncertain. Inform your healthcare provider if you are pregnant or intend to become pregnant before starting treatment. 

The transfer of benztropine into breast milk is uncertain. Seek guidance from your healthcare provider before breastfeeding.